Methods of treating spinal cord injury and minimizing scarring
US8475788B2 · kind B2 · utility
17Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 27, 2007 |
| Grant date | Jul 2, 2013 |
| Priority date | — |
| Expiry date | Aug 25, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K35/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to methods of promoting the healing of spinal cord injury. The invention is further directed to methods of minimizing the extent of scarring following spinal cord injury. Such methods utilize novel compositions, including but not limited to extraembryonic cytokine secreting cells (herein referred to as ECS cells), including, but not limited to, amnion-derived multipotent progenitor cells (herein referred to as AMP cells) and conditioned media derived therefrom (herein referred to as amnion-derived cellular cytokine solution or ACCS), each alone or in combination with each other and/or other agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.